After a two-year pause caused by the pandemic, the NIH project recently stopped in Colorado.
The program is inviting more than a million people from all walks of life to help build what its calling one of the most diverse health databases of its kind and improve medical treatment across diverse groups.
Nevarez agreed to answer survey questions and share medical information, including her DNA from urine and blood. That all goes into the giant research database. Nevarez said shes glad to help.
I think that is a good program. And I think that it's good to do this kind of stuff for everybody, she said.
Nevarez is originally from Mexico. She said that the programs diverse pool will create a powerful tool for researchers.
I think that that's my main purpose to come here, just to show my people, my community. said Nevarez. She leads a diabetes prevention program with Vuela for Health, a health promotion group working with the Latino community. We do have to do this, we do have to participate.
The Hispanic/Latino community represents nearly 20 percent of the U.S. population but only about 5 percent of participants in clinical trials. That same tiny figure is true for Black Americans too, who make up more than 13 percent of the population, according to the program.
Often, people from diverse backgrounds havent been asked to participate or told why its valuable, said Edgar Gil Rico, an All of Us principal investigator with the National Alliance for Hispanic Health. Why is it important for me? Why is it important for the community? he said.
He answers his own question: to help with the development of medicines and treatments that are tailored to each individual. Its whats called precision medicine. He said health is not just a list of different symptoms that you have.
The health of a person is more comprehensive. Where you live, what kinds of activities you do, your family health history, your genetics, all of these play a role in providing you the right treatment for you, he said.
It will improve treatments in the long run, said Jaharri Asten, who came to the bus at the Lowry Family Health Center to provide samples of her DNA.
I know a lot of people, especially minorities, feel like the doctors don't understand their culture, she said. And so having this data will help inform the doctors.
Asten is a counselor in substance abuse and addiction with Denver Health and said better research could help improve treatment based on genetic and cultural differences. So it would definitely be a good idea to have different samples so that medicine could be more specialized for each person, she said.
Asten was excited about potential scientific advancements. I just thought it was really fascinating, she said. Whenever I get the opportunity to participate in research, I do it because you never know who it's gonna help or who could be impacted in the future.
Across the U.S., more than 370,000 participants have completed all the basic enrollment steps, including providing a biosample, either blood, saliva or urine, according to an All of Us press officer.
Offering up your own DNA samples to build that database may be too much, too risky, for some.
But the program says the information is anonymized and the data is protected and secured.
Mayela Picado, a nutritionist from Boulder, said she was comfortable with the tradeoffs.
I know how research works, she said. We are gonna be a number. So my genetics and all my information would be just a number.
Alok Sarwal is a big proponent of this project. He leads a diverse medical clinic with offices in Denver and Aurora, the Colorado Alliance for Health Equity and Practice. It serves 20 ethnicities.
Hes encouraged community members to participate. Not only we are contributing to the database, but we are also now going to be utilizers of the database, said Sarwal, the CEO and co-founder of the clinic. Its mission is to improve the health of the states immigrant communities through culturally and linguistically appropriate prevention, health education, wellness activities, early detection, and self-management of disease.
His colleague, program manager Suegie Park, gave an example of how this information could help. She said theres a popular blood thinner, developed by a pharmaceutical company. Blood thinners are key to stopping blood clots, preventing heart attacks and strokes.
That medication works with white people, research has shown, she said, more than 75 percent of the time. Very effective!
But its less than 50 percent effective for Asians, she said. And a big share of her clinics patients are Pacific Islanders, for whom it doesnt work so well. Its effectiveness with native Hawaiians is only 27 percent.
These kinds of concerns are why the NIH created the project. The agency was well-aware that, oh, we need multi-ethnicity, Park said.
In Colorado, 2,175 participants have completed all the basic steps, including contributing a biosample. Nearly 80 percent identify with a category the program calls underrepresented in biomedical research. This includes racial and ethnic groups, sexual and gender minorities, rural populations, older adults, people with disabilities and those with lower educational attainment and/or income, according to the program.
So far, 17 percent of Colorado program participants identify as Hispanic, according to the program; thats a bit less than their 21.6 percent share of the states population. The numbers for other ethnic groups also trail their share of the Colorado population: 2 percent Black participants, compared to their 4.3 percent portion of the states population, 1 percent Asian (compared with 3.6 percent) and 1 percent American Indian/Alaska Native (compared with 1.7 percent).
The project is also drawing plenty of attention from researchers, like Dr. Nathan Clendenden, an anesthesiologist and professor at the University of Colorado.
He said cardiovascular disease, which includes heart attack and stroke, is the biggest killer. Typically he only studies patients in the hospital. But that is a limited number of patients and often doesnt include everyone in the community, Clendenen said.
I think that's been a blind spot in research is that it's not necessarily representative, he said.
Now Clendenen and his team are exploring a new way to start addressing that problem. Theyve started a new study, about preventing blood clots, using the vast genetic database from the All of Us research program. (The title of the research: Platelet Hyperreactivity as a Therapeutic Target for Reducing Stroke in Older Adults after Transcatheter Aortic Valve Replacement.)
The drugs already exist. So this is really about taking existing tools and matching patients to them, he said.
Clendenen said research done via the database promises to make medicine more precise, ideally personalizing the treatment of individual patients and improving, even saving, lives.
So far, 31 Colorado researchers registered to use the All of Us Researcher Workbench and nearly two dozen research projects have been initiated, according to the program. Those include studies of cardio-metabolic health outcomes, genetic risk factors for thyroid cancer, complications from cataract surgery, and Dr. Clendenens research on platelet reactivity as a risk factor for stroke.
(For more details, search the public Research Projects Directory.)
Another advantage for participants is to learn more about their own DNA. The All of Us program notes on its website it will only show results a participant wants to see.
That information may include genetic ancestry, including where someones family might have lived hundreds of years ago, genetic traits, such as why a person might love or hate cilantro, whether they may have a higher risk for certain health conditions and how ones body might react to certain medications.
Program representatives said you could learn about diseases that you might have, or like if there's any disorders or anything. So, of course, that's interesting, said Asten, who is interested to see what her genetic profile shows. You could see your ancestry and who your most recent ancestors are. So I thought that would be kind of cool too.
- CRISPR: A game-changing genetic engineering technique - January 4th, 2023
- Genetic Counseling Online Course - School of Medicine Columbia ... - January 4th, 2023
- Genetics & Medicine - Site Guide - NCBI - National Center for ... - December 27th, 2022
- Lilly, ProQR to expand genetic medicine development agreement - December 27th, 2022
- Central Dogma and Genetic Medicine - HHMI BioInteractive - November 24th, 2022
- Social, Environmental, Cognitive, and Genetic Influences on the Use of ... - November 24th, 2022
- Genetically modified food controversies - Wikipedia - October 29th, 2022
- BSGM - The British Society for Genetic Medicine - October 13th, 2022
- Genetic and Genomic Medicine - Nationwide Children's Hospital - October 13th, 2022
- Carrier Screening for Genetic Conditions | ACOG - October 13th, 2022
- New NHS genetic testing service could save thousands of children in England - The Guardian - October 13th, 2022
- Vertex, after setbacks, moves forward with second-generation rare disease drug - BioPharma Dive - October 13th, 2022
- Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer - Yahoo Finance - October 13th, 2022
- Metagenomi Announces Participation in October Investor and Industry Conferences - Business Wire - October 4th, 2022
- NovaSeq X machines will make genetic analysis even faster and cheaper - Mezha.Media - October 4th, 2022
- ORYZON to Give Updates on Corporate Progress in October - BioSpace - October 4th, 2022
- e-therapeutics: Fundraise of 13.5 million - BioSpace - October 4th, 2022
- The inheritance of hope curing genetic heart disease now within grasp - British Heart Foundation - October 4th, 2022
- MS Genetic Counseling | Ohio State College of Medicine - September 16th, 2022
- Genetic Counselor - Mayo Clinic College of Medicine & Science - September 16th, 2022
- UCLA researcher awarded National Academy of Medicine prize for work on genetics of autism - Newswise - September 16th, 2022
- Precision Medicine Offers Hope for More Targeted Rash Diagnosis and Treatment - Dermatology Times - September 16th, 2022
- Redmond firefighters to 'Fill the Boot' for Muscular Dystrophy Association - KTVZ - September 16th, 2022
- Why Monkeypox Wasnt Another COVID-19 - FiveThirtyEight - September 16th, 2022
- Endometriosis Researchers One Step Closer to Diagnosing Condition With Menstrual Blood - Business Wire - September 16th, 2022
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 16th, 2022
- Humans evolved with their microbiomes like genes, your gut microbes pass from one generation to the next - The Conversation - September 16th, 2022
- When to Use Targeted Therapy for Iodine-Refractory Thyroid Cancer - Targeted Oncology - September 16th, 2022
- Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - PR Newswire - September 16th, 2022
- CRISPR is 10: A decade of gene editing refinements presents new ways to address agricultural diseases thought to be incurable - Genetic Literacy... - September 16th, 2022
- Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for ... - The Bakersfield Californian - September 8th, 2022
- 'Record' Gains in Bringing Research Closer to the Patient - Applied Clinical Trials Online - September 8th, 2022
- Metagenomi Announces Participation in September Investor and Industry Conferences - Business Wire - September 8th, 2022
- Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy - Yahoo Finance - September 8th, 2022
- Studies Reveal Aggressive Prostate Cancer Linked to Ancestral Heritage - DocWire News - September 8th, 2022
- Lonza and Touchlight collaboration will expands customer's access to DNA - Labiotech.eu - September 8th, 2022
- Genetic variants in miR-145 gene are associated with the risk of asthma in Taiwan | Scientific Reports - Nature.com - September 8th, 2022
- Elderly are more affected by COVID brain fog, but 'cognitive rehab' could be an effective treatment - Genetic Literacy Project - September 8th, 2022
- A therapy found to improve cognitive function in patients with Down syndrome - EurekAlert - September 8th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 30th, 2022
- Morris Animal Foundation Golden Retriever Lifetime Study Celebrates 10 Years - PR Newswire - August 30th, 2022
- Immortal jellyfish genes identified that may explain their long lives - New Scientist - August 30th, 2022
- Walk Again Or Stop Blindness. How Gene Therapy Is Revolutionizing Medicine - Nation World News - August 30th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 30th, 2022
- Therapeutic Effects of Tretinoin | JIR - Dove Medical Press - August 30th, 2022
- Physical Activity May Have a Stronger Role than Genes in Longevity - Newswise - August 30th, 2022
- BridgeBio, Baylor College of Medicine to Collaborate on Genetic Disease ... - August 22nd, 2022
- New $2.8-million gene therapy becomes most expensive medicine in history - New Atlas - August 22nd, 2022
- Molecular Map Reveals Insights Into the Genetic Drivers of CLL - The ASCO Post - August 22nd, 2022
- Biopharmaceutical Company Expands Clinical Trials On Texas A&M-Developed Angelman Syndrome Treatment - Texas A&M University Today - August 22nd, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo News - August 22nd, 2022
- Marketing and Industry Trends Influencing Precision Medicine in 2022 - Healthcare Tech Outlook - August 22nd, 2022
- expert reaction to study investigating use of genetic risk score for prostate cancer in men with lower urinary tract symptoms to predict diagnosis -... - August 22nd, 2022
- As the Smithsonian wraps a genome exhibit, leaders in the field reflect - STAT - August 22nd, 2022
- Why some people suffer more from COVID-19 than others - EurekAlert - August 22nd, 2022
- Q3 2022 Earnings Forecast for LogicBio Therapeutics, Inc. Issued By William Blair (NASDAQ:LOGC) - Defense World - August 22nd, 2022
- Next generation patient avatars: Expanding the possibilities with MicroOrganospheres - EurekAlert - August 22nd, 2022
- Masters Program in Genetic Counseling - Perelman School of Medicine at ... - August 14th, 2022
- Admissions | Master's Program in Human Genetics & Genetic Counseling ... - August 14th, 2022
- The Silver Lining Of Innovation in Genetic Medicine - Pharmaceutical Executive - August 14th, 2022
- Genetics Team Serves as Go-to for Mom of Son With Extremely Rare Disorder - Stanford Medicine Children's Health Blog - Stanford Children's Health - August 14th, 2022
- UI professor receives grant from National Institutes of Health - Iowa Now - August 14th, 2022
- Lilly's Taltz (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce Injection Site Pain for Improved Patient Experience - PR Newswire - August 14th, 2022
- Research Roundup: 21 Genes Linked to Increased Risk of Alzheimer's and More - BioSpace - August 14th, 2022
- Personalised medicine made in hospitals can revolutionise the way diseases are treated the challenge now will be implementing it - The Conversation... - August 14th, 2022
- Beyond Paxlovid for covid-19: The hunt for better covid medications - Grid - August 14th, 2022
- PVM to Play Role in Research on New Patent-pending Method to Mass-produce Antitumor Cells to Treat Blood Diseases and Cancer - Purdue University - August 14th, 2022
- Analyzing Kiromic BioPharma (NASDAQ:KRBP) and LogicBio Therapeutics (NASDAQ:LOGC) - Defense World - August 14th, 2022
- Corporate America's Abortion Radicalism - The American Conservative - August 14th, 2022
- A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end 'parachute science,' too? - STAT - August 14th, 2022
- The aging heart accumulates mutations while losing the ability to repair them - EurekAlert - August 14th, 2022
- Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results - GuruFocus.com - August 5th, 2022
- Population Genetic Testing: Save Lives And Money, While Avoiding Financial Toxicity - Forbes - August 5th, 2022
- Genetic Counselors Scramble Post- Roe to Provide Routine Pregnancy Services without Being Accused of a Crime - Scientific American - August 5th, 2022
- GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - August 5th, 2022
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results - Yahoo Finance - August 5th, 2022
- Researchers discover one of the largest known bacteria-to-animal gene transfer inside a fruit fly - EurekAlert - August 5th, 2022
- Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Yahoo Finance - August 5th, 2022
- Medical Student's Crime In Cipolletti: They Found A Man's DNA Under The Victim's Thumb - Nation World News - August 5th, 2022
- A new era: After winding path and safety scares, gene therapy enters the clinic - Sydney Morning Herald - August 5th, 2022